Replies to post #5791 on Talon Therapeutics Inc (fka TLON)

[viki]

<There can be no assurance as to the actual value, if any, of a CVR, which will depend on numerous factors. The CVRs will not be publicly traded. The per share purchase price for each outstanding share of Company common stock payable at closing to the Company's stockholders, including the Company's principal stockholders, is approximately $0.056 in cash plus one CVR right.>

whatever that is worth.